Skip to main content

Nifty -0.8%: breadth eroding, not a dip to buy

Decliners led 1,651 to 560, the fast breadth gauge has collapsed — this is distribution, not consolidation.

Wednesday, 22 July 20262 min readStage2Stocks Market Desk

Nifty 50
23,996
-0.8% on the day
Market
Neutral — Building
36 sessions in this state
Breadth
42%
above 200-DMA · narrow
Adv / Dec
560 / 1,651
decliners ahead
52w highs / lows
132 / 105
net +27
Stage-2 share
33%
cohort widening

The tape is hollowing out, not pulling back inside strength. Today's -0.8% on Nifty 50 to 23,996 came with decliners swamping advancers 1,651 to 560 and net new highs collapsing to 27 — the worst reading in six sessions. This is breadth eroding under a weakening index, and the honest read is that the regime, weak but recovering for 36 days, is at risk of losing even that qualifier.

Trajectory: the internals are telling a clear story

The slow structural gauge — the share of stocks above their 200-day average — has slid from 44.2% on 15 July to 41.8% today, a steady five-session bleed that confirms the damage is not cosmetic. The fast short-term gauge has been worse: it peaked at 45.6% last Tuesday and has crashed to 36.1% today, its sharpest single-session drop in the series. Advance-decline has gone from roughly balanced on 20–21 July to a 3-to-1 rout today, and net new highs have shrunk from 93 to 27. Over the last five days, 60 stocks degraded from Stage 2 to Stage 3 against only 40 moving the other way — the advancing cohort is contracting at the margin, not widening. A single down day inside a healthy tape does not look like this.

Leadership: defensive and narrow, with one pocket of structural interest

Consumer Staples was the only sector to close in the green today, up 0.3% — that is a defensive rotation, not a risk-on signal. Over one and three months, Health Care and Real Estate remain the structural leaders, and Health Care is also where the Stage-2 cohort is expanding fastest, with RPG Life Sciences among the names that cleared the screen. Information Technology is the other sector where the Stage-2 cohort has been widening over 20 days — notable given it is the three-month laggard at -5.8% — but a sector rebuilding from a base in a deteriorating tape is a watch-list item, not a conviction call. On a day when fewer than a third of stocks are above their 20-day average, the screen surfaces names like Lokesh Machines and Kapston Services in Industrials with strong setup scores, but the backdrop argues that follow-through rates on fresh breakouts will be lower than usual.

Leading Stage-2 setups
StockSectorSetup% 1D
Lokesh Machines LtdIndustrials9.8+0.3%
Muthoot Microfin LtdFinancials9.4-1.6%
Kapston Services LtdIndustrials9.4+2.8%
RPG Life Sciences LtdHealth Care9.4+0.2%
Sky Gold and Diamonds LtdConsumer Discretionary9.4+2.4%
Gandhar Oil Refinery (INDIA) LtdEnergy9.0+4.0%
Bharat Seats LtdConsumer Discretionary9.0-1.1%
Macpower CNC Machines LtdIndustrials8.9-0.5%
Sector performance — cap-weighted, ranked by today’s move
Sector1D1M3MRSStage 2
Consumer Staples+0.3%+0.2%-1.4%5426%
Consumer Discretionary-0.1%+2.1%+4.0%6835%
Communication Services-0.6%+1.6%+9.8%6616%
Energy-0.7%-0.4%-2.2%5729%
Materials-0.8%-0.8%+2.1%7032%
Industrials-0.9%-3.1%+9.2%6937%
Utilities-1.0%-3.5%+3.8%6318%
Information Technology-1.1%+1.8%-5.8%4131%
Health Care-1.3%+4.1%+16.6%7350%
Financials-1.3%-0.9%-2.8%6134%
Real Estate-2.2%+9.0%+12.5%5122%
Share of NSE stocks in Stage 2Jan 2026 – Jul 2026 · weekly
0%10%20%30%40%50%60%70%Jul 26Nifty 50Stocks in Stage 2Latest: 35%
The share of NSE stocks in Stage 2 over the six months to this wrap, with the Nifty's shape above it: the market underneath the day's numbers. Source: Stage2Stocks classification of every NSE stock with enough history, each week.
Try it on Stage2StocksHow to read this chart Lesson 3 of the course: why the Nifty isn't the market, and what the share of stocks in Stage 2 tells you.

Work the same data live: open the full stock screener, watch the live market dashboard, or check the market-timing read. New to the method? Start with the four stages.

Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.

All market wraps →